Publication | Open Access
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>177</sup>Lu-Labeled PSMA-617
598
Citations
28
References
2016
Year
(177)Lu-PSMA-617 is a promising new option for therapy of mCRPC and deserves more attention in larger prospective trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1